CC-223
Showing 1 - 25 of 1,199
Lymphoma, Large B-Cell, Diffuse Trial in Worldwide (CC-122, CC-223, Rituximab)
Active, not recruiting
- Lymphoma, Large B-Cell, Diffuse
- CC-122
- +3 more
-
Santa Barbara, California
- +22 more
Jan 25, 2023
Prostate Cancer Trial in Montreal (radium-223 dichloride)
Completed
- Prostate Cancer
- radium-223 dichloride
-
Montreal, Quebec, CanadaJewish General Hospital
Sep 20, 2021
Safety and Pharmacokinetics in Healthy Volunteer Subjects Trial in Madison (CC-223)
Completed
- Safety and Pharmacokinetics in Healthy Volunteer Subjects
- CC-223
-
Madison, WisconsinCovance Research Unit, Inc
Nov 7, 2019
NSCLC, NSCLC Trial in Spain, United States (CC-223, erlotinib, CC-223, oral azacitidine)
Completed
- Carcinoma, Non-Small-Cell Lung
- Non-Small Cell Lung Cancer
- CC-223, erlotinib
- CC-223, oral azacitidine
-
Los Angeles, California
- +8 more
Nov 7, 2019
Biochemical Recurrent Prostate Cancer Trial run by the National Cancer Institute (NCI) (Radium-223, 18F Sodium Fluoride)
Recruiting
- Biochemical Recurrent Prostate Cancer
- Radium-223
- 18F Sodium Fluoride
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Learn More About How Radium-223 is Being Used With Other
Active, not recruiting
- Bone Metastatic Castration-resistant Prostate Cancer
- Radium 223 dichloride (Xofigo, BAY88-8223)
-
Multiple Locations, Denmark
- +2 more
Jan 16, 2023
Hypertension,Essential Trial in Seoul (AD-223A, AD-223B, AD-223C)
Not yet recruiting
- Hypertension,Essential
- AD-223A
- +5 more
-
Seoul, Korea, Republic ofHanyang University Hospital
Sep 19, 2023
Castration-Resistant Prostate Carcinoma, Metastatic Malignant Tumor in the Lymph Nodes, Metastatic Prostate Carcinoma Trial in
Recruiting
- Castration-Resistant Prostate Carcinoma
- +3 more
- Avelumab
- +4 more
-
Los Angeles, California
- +22 more
Feb 2, 2023
Anatomic Stage IV Breast Cancer AJCC v8, Hormone Receptor-Positive Breast Carcinoma, Metastatic Breast Carcinoma Trial in United
Recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- +5 more
- Biospecimen Collection
- +4 more
-
Birmingham, Alabama
- +26 more
Jan 25, 2023
Advanced Renal Cell Carcinoma, Chromophobe Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma Trial in United States (drug,
Recruiting
- Advanced Renal Cell Carcinoma
- +8 more
- Cabozantinib S-malate
- +3 more
-
Birmingham, Alabama
- +35 more
Jan 24, 2023
GCF miRNA-223 , -214 Levels in Smokers and Nonsmokers
Completed
- Periodontitis, Adult
- miRNA-223 & -214 detection
-
Fayoum, Egyptfaculty of dentistry, Fayoum university
Sep 26, 2023
Treatment Satisfaction With Ra-223 in Japan
Active, not recruiting
- Prostatic Neoplasms
- Radium-223 dichloride (Xofigo, BAY88-8223)
-
Multiple Locations, JapanMany Locations
Jan 12, 2023
Prostate Cancer Trial in Boston (Radium-223, Pembrolizumab)
Active, not recruiting
- Prostate Cancer
-
Boston, Massachusetts
- +1 more
Aug 31, 2022
How Radium-223 Dichloride,Alpha Particle-emitting Radioactive
Recruiting
- Castration-resistant Prostate Cancer
- Radium-223 dichloride (Xofigo, BAY88-8223)
-
Multiple Locations, TaiwanMany locations
Aug 19, 2022
Local Anaesthetic Drug Adverse Reaction Trial in Alexandria (Dental Local Anaesthesia)
Completed
- Local Anaesthetic Drug Adverse Reaction
- Dental Local Anaesthesia
-
Alexandria, EgyptAlexandria University
Nov 11, 2021
Acromioclavicular Joint Dislocation Trial in Chon Buri (K-wire)
Recruiting
- Acromioclavicular Joint Dislocation
- K-wire
-
Chon Buri, ThailandQueen Savang Vadhana Memorial Hospital
May 2, 2023
Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8 Trial in United
Recruiting
- Castration-Resistant Prostate Carcinoma
- +2 more
- Laboratory Biomarker Analysis
- +3 more
-
La Jolla, California
- +21 more
Dec 2, 2022
Telomere Length Trial in Abu Dhabi (First polar body biopsy in MII oocytes, PGT-A blastocyst)
Recruiting
- Telomere Length
- First polar body biopsy in MII oocytes
- PGT-A blastocyst
-
Abu Dhabi, United Arab EmiratesART Fertility Clinics
Jun 8, 2021
Biomechanical Coupling of Brain and Skull
Recruiting
- Traumatic Brain Injury (Tbi)
- Traumatic Meningeal Enhancement (Tme)
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Prostate Cancer Trial in Netherlands, United States (Docetaxel 75 mg/m2, Docetaxel 60 mg/m2, Radium-223)
Recruiting
- Prostate Cancer
- Docetaxel 75 mg/m2
- +2 more
-
Gilbert, Arizona
- +52 more
Feb 2, 2023
Castration-Resistant Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Stage IVB Prostate Cancer AJCC v8 Trial in San
Not yet recruiting
- Castration-Resistant Prostate Carcinoma
- +2 more
- Radium-223
- +2 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Jun 20, 2023